Lake Norman Hematology/ Oncology Specialists

Mooresville, North Carolina 28117

0 studies enrolling now · 3 studies all time

What they study most

Advanced Prostate Cancer, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Breast Neoplasms, Lung Cancer, Non-small-cell Lung Carcinoma, Prostatic Neoplasms

Studies at this site

• A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) — Completed
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed
• A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed